Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Goodwill (2022 - 2024)

Pasithea Therapeutics (KTTA) has disclosed Goodwill for 3 consecutive years, with $1.3 million as the latest value for Q3 2024.

  • Quarterly Goodwill changed 0.0% to $1.3 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Sep 2024, changed 0.0% year-over-year, with the annual reading at $1.3 million for FY2023, 0.0% changed from the prior year.
  • Goodwill hit $1.3 million in Q3 2024 for Pasithea Therapeutics, roughly flat from $1.3 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $3.9 million in Q3 2022 to a low of $1.3 million in Q4 2022.
  • Historically, Goodwill has averaged $1.8 million across 3 years, with a median of $1.3 million in 2022.
  • Biggest YoY gain for Goodwill was 0.0% in 2023; the steepest drop was 67.23% in 2023.
  • Year by year, Goodwill stood at $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024.
  • Business Quant data shows Goodwill for KTTA at $1.3 million in Q3 2024, $1.3 million in Q2 2024, and $1.3 million in Q1 2024.